Market Tracker

08/01 6:05pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

20.88
Data as of Aug 01
 -0.30 / -1.42%
Today’s Change
15.61
Today|||52-Week Range
53.48
-5.13%
Year-to-Date
No recent news for NewLink Genetics Corp.

Today’s Trading

Previous close21.18
Today’s open21.17
Day’s range20.01 - 21.47
Volume205,920
Average volume (3 months)319,116
Market cap$590.4M
Dividend yield--
Data as of 4:00pm ET, 08/01/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-36.91%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book9.65

Competitors

 Today’s
change
Today’s
% change
OREXOrexigen Therapeutic...-0.02-0.40%
MACKMerrimack Pharmaceut...-0.13-2.20%
MGNXMacroGenics Inc-0.42-2.07%
HZNPHorizon Pharma Inc+0.23+2.70%
Data as of 4:00pm ET, 08/01/2014

Financials

Next reporting dateAugust 6, 2014
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts